Ellex/Quantel Medical will present a new intense pulsed light (IPL) system for dry eye disease on its virtual booth at the RANZCO Congress later this month.
Read More
Aussie firm reveals next-gen MIGS device in pipeline
Adelaide ophthalmic device manufacturer Nova Eye Medical is developing a next generation iTrack glaucoma surgical system to reduce operating times. It is also progressing towards a pivotal US study for its 2RT laser therapy for intermediate AMD that could fulfil a distinct gap in a multi-billion-dollar market.
Read More
Read More
Nova Eye Medical buys New Zealand glaucoma business
Newly renamed Adelaide ophthalmic device manufacturer Nova Eye Medical has immediately delivered on a plan to expand its glaucoma portfolio, with the AU$921,000 acquisition of a New Zealand-developed drainage device platform.
Read More
Read More
Ellex shareholders approve sale; company to operate under new name
Ellex Medical Lasers shareholders have backed the $100 million sale of the lasers and ultrasound business to Lumibird Group. They also agreed to re-name the company Nova Eye Medical, forming a debt-free entity with a long-term focus on glaucoma therapies.
Read More
Read More
Ellex CEO steps down as company shifts to new business model
Further leadership changes have occurred at Ellex Medical Lasers with the resignation of its interim CEO, as the company prepares to offload its lasers and ultrasound business to focus on higher growth ophthalmic segments.
Read More
Read More
French company to acquire Ellex assets in multi-million-dollar deal
Ellex Medical Lasers has agreed to sell its laser and ultrasound business segment to French company Lumibird Group for $100 million.
Read More
Read More